13F HOLDINGS REPORT
Euclidean Capital LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001012975-25-000088
Total Value
$736.7M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 896,254 | $525.3M | 71.30% |
| 2 | ISHARES TR | 46429B598 | 2,425,144 | $127.7M | 17.33% |
| 3 | VANGUARD INTL EQUITY INDEX F | 922042775 | 1,013,434 | $58.2M | 7.90% |
| 4 | ORIC PHARMACEUTICALS INC | ORIC | 989,410 | $8.0M | 1.08% |
| 5 | FOGHORN THERAPEUTICS INC | FHTX | 1,573,761 | $7.4M | 1.01% |
| 6 | PMV PHARMACEUTICALS INC | PMVP | 2,627,643 | $4.0M | 0.54% |
| 7 | ALECTOR INC | ALEC | 1,307,858 | $2.5M | 0.34% |
| 8 | TENAYA THERAPEUTICS INC | TNYA | 1,015,705 | $1.5M | 0.20% |
| 9 | SURROZEN INC | SRZNW | 87,696 | $1.3M | 0.17% |
| 10 | RAPT THERAPEUTICS INC | 75382E109 | 657,899 | $1.0M | 0.14% |
| 11 | SURROZEN INC | SRZNW | 170,833 | $3,656 | 0.00% |